This study focuses on the oncogene ST14, encoding the type II transmembrane protease Matriptase-1 that upon hyperactivation—as for instance due to genetic loss of its cognate transmembrane inhibitor Hai1—can drive different carcinomas. This evidence concerns the gene ST14 and carcinoma.